Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol
Journal – International Journal of Surgery Protocols
Article type – Journal research article – Other
Publication date – Jun – 2021
Authors – Gideon Adegboyega, Ulrick Sidney Kanmounye , Tatjana Petrinic, Ahmad Ozair, Soham Bandyopadhyay, Ashvin Kuri, Yvan Zolo, Katya Marks, Serena Ramjee, Ronnie E. Baticulon, Babar Vaqas
Keywords – glioblastoma multiforme, Global neurosurgery, healthcare disparities, Low-and middle-income countries, neuro-oncology, systematic review protocol
Open access – Yes
Speciality – Neurosurgery, Surgical oncology
World region Global
Language – English
Submitted to the One Surgery Index on July 2, 2021 at 11:51 pm
Background: Glioblastoma multiforme is the most common and aggressive primary adult brain neoplasm. The current standard of care is maximal safe surgical resection, radiotherapy with concomitant temozolomide, followed by adjuvant temozolomide according to the Stupp protocol. Although the protocol is well adopted in high-income countries (HICs), little is known about its adoption in low- and middle-income countries (LMICs). The aim of this study is to describe a protocol design for a systematic review of published studies outlining the differences in GBM management between HICs and LMICs.
Methods: A systematic review will be conducted. MedLine via Ovid, Embase and Global Index Medicus will be searched from inception to date in order to identify the relevant studies. Adult patients (>18 years) with histologically confirmed primary unifocal GBM will be included. Surgical and chemoradiation management of GBM tumours will be considered. Commentaries, original research, non-peer reviewed pieces, opinion pieces, editorials and case reports will be included.
Results: Primary outcomes will include rates of complications, disability-adjusted life years (DALYs), prognosis, progression-free survival (PFS), overall survival (OS) as well as rate of care abandonment and delay. Secondary outcomes will include the presence of neuro-oncology subspecialty training programs.
Discussion: This systematic review will be the first to compare the current landscape of GBM management in HICs and LMICs, highlighting pertinent themes that may be used to optimise treatment in both financial brackets.
Systematic Review Registration: The protocol has been registered on the International Prospective Register of Systematic Reviews (PROSPERO; registration number: CRD42020215843).
OSI Number – 21162